Stock listing
Tenaya Therapeutics, Inc.
Selected listing: TNYA · NASDAQ · USD · US
Tenaya Therapeutics, Inc. (NASDAQ:TNYA), Health Technology. Latest release Sep 14, 2026: Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced…
- Ticker
- NASDAQ:TNYA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Tenaya Therapeutics, Inc.
The company focuses on developing innovative therapies for heart diseases. Tenaya is committed to advancing its research and product pipeline to address unmet medical needs in cardiovascular health.
Latest news from Tenaya Therapeutics, Inc.
Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
September 14, 2026
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 5, 2026
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
August 4, 2026
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
June 29, 2026
Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms
June 3, 2026
Research Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. company profile
View the public company page for Tenaya Therapeutics, Inc. on 6ix.
Tenaya Therapeutics, Inc. news
Read company news and market updates connected to Tenaya Therapeutics, Inc..
Tenaya Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Tenaya Therapeutics, Inc..